BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6134095)

  • 1. Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.
    Elder GH; Sheppard DM; Tovey JA; Urquhart AJ
    Lancet; 1983 Jun; 1(8337):1301-4. PubMed ID: 6134095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
    Elder GH; Urquhart AJ; De Salamanca RE; Munoz JJ; Bonkovsky HL
    Lancet; 1985 Aug; 2(8449):229-33. PubMed ID: 2862415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of familial porphyria cutanea tarda.
    Roberts AG; Elder GH; Newcombe RG; Enriquez de Salamanca R; Munoz JJ
    J Med Genet; 1988 Oct; 25(10):669-76. PubMed ID: 3225822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.
    de Verneuil H; Beaumont C; Deybach JC; Nordmann Y; Sfar Z; Kastally R
    Am J Hum Genet; 1984 May; 36(3):613-22. PubMed ID: 6375356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule?
    D'Alessandro Gandolfo L; Griso D; Macri A; Biolcati G; Topi GC
    Dermatologica; 1989; 178(4):206-8. PubMed ID: 2767288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients.
    Held JL; Sassa S; Kappas A; Harber LC
    J Invest Dermatol; 1989 Sep; 93(3):332-4. PubMed ID: 2768832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1985 Mar; 127(2):517-25. PubMed ID: 3977935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uroporphyrinogen decarboxylase deficiency in hepatoerythropoietic porphyria: further evidence for genetic heterogeneity.
    Kószó F; Elder GH; Roberts A; Simon N
    Br J Dermatol; 1990 Mar; 122(3):365-70. PubMed ID: 2322500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects.
    Elder GH; Roberts AG; de Salamanca RE
    Clin Biochem; 1989 Jun; 22(3):163-8. PubMed ID: 2786774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyria cutanea tarda: erythrocyte uroporphyrinogen decarboxylase activity in 471 consecutive patients.
    Doss MO; Frank M; Braun-Falco O
    Curr Probl Dermatol; 1991; 20():97-105. PubMed ID: 1935224
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial porphyria cutanea tarda: hybridization analysis of the uroporphyrinogen decarboxylase locus.
    Hansen JL; O'Connell P; Romana M; Romeo PH; Kushner JP
    Hum Hered; 1988; 38(5):283-6. PubMed ID: 2906904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
    Elder GH; Sheppard DM; De Salamanca RE; Olmos A
    Clin Sci (Lond); 1980 Jun; 58(6):477-84. PubMed ID: 7428280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda.
    Garey JR; Harrison LM; Franklin KF; Metcalf KM; Radisky ES; Kushner JP
    J Clin Invest; 1990 Nov; 86(5):1416-22. PubMed ID: 2243121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda.
    Garey JR; Hansen JL; Harrison LM; Kennedy JB; Kushner JP
    Blood; 1989 Mar; 73(4):892-5. PubMed ID: 2920211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda.
    Kószó F; Morvay M; Dobozy A; Simon N
    Br J Dermatol; 1992 May; 126(5):446-9. PubMed ID: 1610684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enzymatic defects in porphyria cutanea tarda and variegate porphyria.
    Kushner JP
    Acta Derm Venereol Suppl (Stockh); 1982; 100():51-6. PubMed ID: 6962633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enzymatic defect in porphyria cutanea tarda.
    Kushner JP
    N Engl J Med; 1982 Apr; 306(13):799-800. PubMed ID: 7062954
    [No Abstract]   [Full Text] [Related]  

  • 19. An assay of uroporphyrinogen decarboxylase in erythrocytes.
    McManus J; Blake D; Ratnaike S
    Clin Chem; 1988 Nov; 34(11):2355-7. PubMed ID: 3180434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state levels of uroporphyrinogen decarboxylase mRNA in lymphoblastoid cell lines from patients with familial porphyria cutanea tarda and their relatives.
    Hansen JL; Pryor MA; Kennedy JB; Kushner JP
    Am J Hum Genet; 1988 Jun; 42(6):847-53. PubMed ID: 3369447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.